ScholarLens Back to search
2023•Unpublished venueOpen access

Figure S1 from Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome

Jules L. Derks, Noémie Leblay, Erik Thunnissen, Robert Jan van Suylen, Michael den Bakker, Harry J.M. Groen, Egbert F. Smit, Ronald Damhuis, Esther C. van den Broek, Amélie Charbrier, Matthieu Foll, James McKay, Lynnette Fernandez‐Cuesta, Ernst‐Jan M. Speel, Anne‐Marie C. Dingemans

Open full text 0 citations

Abstract

A) Overall survival according to the original established diagnosis in patients included in the panel-consensus revision (n=232). B) Overall survival according to the panel-consensus diagnoses. Abbreviations: NSCLC NED, non-small cell lung carcinoma with neuroendocrine differentiation; NEC, neuroendocrine carcinoma; dd, differential diagnosis; NET NOS, neuroendocrine tumor not otherwise specified.

About this research paper

What this paper is about

A) Overall survival according to the original established diagnosis in patients included in the panel-consensus revision (n=232). B) Overall survival according to the panel-consensus diagnoses. Abbreviations: NSCLC NED, non-small cell lung carcinoma with neuroendocrine differentiation; NEC, neuroendocrine carcinoma; dd, differential diagnosis; NET NOS, neuroendocrine tumor not otherwise specified.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A) Overall survival according to the original established diagnosis in patients included in the panel-consensus revision (n=232). B) Overall survival according to the panel-consensus diagnoses. Abbreviations: NSCLC NED, non-small cell lung carcinoma with neuroendocrine differentiation; NEC, neuroendocrine carcinoma; dd, differential diagnosis; NET NOS, neuroendocrine tumor not otherwise specified.

Key concepts: Neuroendocrine carcinoma, Chemotherapy, Small Cell Lung Carcinoma, Medicine, Internal medicine, Oncology, Neuroendocrine tumors, Lung

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Figure S1 from Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome — Research Paper | ScholarLens